pbc

Documents about pbc

• Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)#1419313ClinicalTrials.gov
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis#991760ClinicalTrials.gov
• Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)#917353ClinicalTrials.gov
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)#1421705ClinicalTrials.gov
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)#899811ClinicalTrials.gov
• Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)#1059624ClinicalTrials.gov
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)#1126999ClinicalTrials.gov
• 75FCMC23F0001 — NAVA PBC — Department of Health and Human Services ($33,177,928)#602031USAspending
• FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy#1370630ClinicalTrials.gov
• Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC)#895592ClinicalTrials.gov
• 75P00124F37001 — NAVA PBC — Department of Health and Human Services ($23,401,045)#602521USAspending
• Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)#891205ClinicalTrials.gov
• A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction#1212332ClinicalTrials.gov
• Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients#1030678ClinicalTrials.gov
• Prenatal Nutrient Status Study#982462ClinicalTrials.gov
• A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients#993389ClinicalTrials.gov
• Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression#1057176ClinicalTrials.gov
• Early Release - Eureka Math TEKS Edition - a Story of Units#1330918Open Library
• Early Release - Eureka Math TEKS Edition - a Story of Units#1331695Open Library
• Early Release - Eureka Math TEKS Edition - a Story of Units#1332243Open Library
• Early Release - Eureka Math TEKS Edition - a Story of Units#1332317Open Library
• Early Release - Eureka Math TEKS Edition - a Story of Units#1332408Open Library
• Early Release - Eureka Math TEKS Edition - a Story of Units#1332449Open Library
• Combination Antiretroviral Therapy (cART) for PBC#893213ClinicalTrials.gov
• Austrian PBC Registry#852936ClinicalTrials.gov
• Clinical Study to Assess the Effects of Prebiotic and Probiotic Supplement#801542ClinicalTrials.gov
• Studying Glucose and Appetite Response With Alternatives to Soda Pop#980716ClinicalTrials.gov
• Swiss Primary Biliary Cholangitis Cohort Study#1293644ClinicalTrials.gov
• On IDA-PBC with Maximum Energy Shapeability#1328363arXiv (All)
• The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland#872691ClinicalTrials.gov
• Use of Fenofibrate for Primary Biliary Cirrhosis#1352534ClinicalTrials.gov
• Study to Evaluate the Efficacy of Bite's Natural Deodorant#842554ClinicalTrials.gov
• Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients#868209ClinicalTrials.gov
• sCD163 in PBC Patients - Assessment of Treatment Response#1260948ClinicalTrials.gov
• A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)#1396226ClinicalTrials.gov
• Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis#651143ClinicalTrials.gov
• INS-1E PBC#1056836CaltechDATA
• sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis#1103712ClinicalTrials.gov
• Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms#1153114ClinicalTrials.gov
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis#1261205ClinicalTrials.gov
• A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation#1230050ClinicalTrials.gov
• A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults#867608ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants#1114485ClinicalTrials.gov
• Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms#1162209ClinicalTrials.gov
• The Value of Spleen Stiffness Measurement in Patients With PBC#902473ClinicalTrials.gov
• An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients#1073104ClinicalTrials.gov
• Discrete IDA-PBC Design for 2D Port-Hamiltonian Systems#1157877HAL Science
• A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA#1230528ClinicalTrials.gov
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis#1418818ClinicalTrials.gov
• Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting#806449ClinicalTrials.gov